We are actively researching the causes and treatments of these disorders as well as collaborating with leading centers around the country to offer our patients the best treatments available. We are also researching various aspects of ITP diagnosis and therapy. Upcoming projects include development of ITP and AIHA registries to understand the natural history of these disorders in children.
Immune hematology researchers are conducting lab-based research to investigate variability in treatment response to commonly used front-line agents in ITP. Additionally, we are working on several projects that will help improve our understanding of the natural history of autoimmune hemolytic anemia and ITP in children, specifically the association with other autoimmune disorders such as systemic lupus erythematosus (SLE) and common variable immune deficiency (CVID).
Renowned for our research and therapies for blood disorders, Texas Children’s Hematology Center physicians conducts state-of-the-art clinical and scientific research aimed at understanding, preventing and curing blood diseases.